Silence Therapeutics Plc American Depository Share SLN
$13.61
-3.48%
at last close
Analyst Consensus
- Consensus Rating
- Buy (3 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $53.50
- Implied Upside
- +293.1%
- Price Target Range
- $32.00 – $75.00
- Analysts (12 mo)
- 3
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-11 | Morgan StanleyMichael Ulz |
Maintains | Overweight | $25 → $32 |
| 2026-06-24 | Cantor FitzgeraldPrakhar Agrawal |
Initiates coverage on | Overweight | — |
| 2026-06-17 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $75 |
| 2026-03-13 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $75 |
| 2025-09-16 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $75 |
| 2025-08-08 | Chardan CapitalKeay Nakae |
Maintains | Buy | $35 |
| 2025-06-13 | HC Wainwright & Co.Patrick Trucchio |
Reiterates | Buy | $75 |
| 2025-06-13 | Chardan CapitalKeay Nakae |
Maintains | Buy | $35 |
| 2025-05-09 | Goldman Sachs Richard Law |
Maintains | Sell | $4 → $3 |
| 2025-05-09 | Morgan StanleyMichael Ulz |
Maintains | Overweight | $45 → $25 |
| 2025-05-09 | Chardan CapitalKeay Nakae |
Maintains | Buy | $55 → $35 |
| 2025-03-07 | HC Wainwright & Co.Patrick Trucchio |
Reiterates | Buy | $75 |
| 2025-03-05 | Morgan StanleyMichael Ulz |
Maintains | Overweight | $49 → $45 |
| 2025-03-04 | BMO CapitalKostas Biliouris |
Maintains | Outperform | $67 → $25 |
| 2025-03-04 | Goldman Sachs Richard Law |
Maintains | Sell | $6 → $4 |
| 2025-02-11 | Goldman Sachs Richard Law |
Initiates coverage on | Sell | $6 |
| 2025-02-03 | HC Wainwright & Co.Patrick Trucchio |
Reiterates | Buy | $75 |
| 2025-01-29 | HC Wainwright & Co.Patrick Trucchio |
Reiterates | Buy | $75 |
| 2024-12-10 | Chardan CapitalKeay Nakae |
Maintains | Buy | $55 |
| 2024-12-09 | HC Wainwright & Co.Patrick Trucchio |
Reiterates | Buy | $75 |
| 2024-11-20 | HC Wainwright & Co.Patrick Trucchio |
Reiterates | Buy | $75 |
| 2024-11-15 | HC Wainwright & Co.Patrick Trucchio |
Reiterates | Buy | $75 |
| 2024-11-14 | Chardan CapitalKeay Nakae |
Maintains | Buy | $55 |
| 2024-10-08 | Morgan StanleyMichael Ulz |
Reiterates | Overweight | $49 |
| 2024-08-30 | HC Wainwright & Co.Patrick Trucchio |
Reiterates | Buy | $75 |
| 2024-08-16 | Chardan CapitalKeay Nakae |
Maintains | Buy | $55 |
| 2024-06-28 | Morgan StanleyMichael Ulz |
Maintains | Overweight | $45 → $49 |
| 2024-06-28 | Chardan CapitalKeay Nakae |
Maintains | Buy | $42 → $55 |
| 2024-06-27 | HC Wainwright & Co.Patrick Trucchio |
Reiterates | Buy | $75 |
| 2024-06-20 | HC Wainwright & Co.Patrick Trucchio |
Reiterates | Buy | $75 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $13.61
- Market Cap
- $845.92 million
- 52-Week Range
- $4.19 – $17.58
- Average Volume
- 1.43 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.